MoneyWorks4Me

Wockhardt informs about press release

11 Dec 2023 Evaluate
Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1788.00
Dr. Reddys Labs. 1201.50
Cipla 1327.10
Lupin 2009.05
Zydus Lifesciences 1141.00
View more..